The global newborn screening market is anticipated to grow at a CAGR of 7.80% during the forecast period (2023-2030). Newborn screening, crucial for early diagnosis of congenital disorders, aids in timely medical intervention, preventing potential health impacts. Screening panels encompass tests for metabolic disorders, hearing impairments, and congenital heart diseases, with some programs incorporating region-specific tests. The market's growth is significantly influenced by comprehensive research and global data collection efforts.
Browse the full report description of “Newborn Screening Market Size, Share & Trends Analysis Report by Technology (Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry (LC-MS/MS), Pulse Oximetry, DNA Microarrays and Next-Generation Sequencing (NGS), Enzyme Based Assays, and Others), by Test Type (Blood Spot Screening, Hearing Screening, Pulse Oximetry Screening, Critical Congenital Heart Defect (CCHD), and Others), and by End-User (Hospitals and Birthing Centers, Neonatal Intensive Care Units (NICUs), Diagnostic Centers, Researchers and Scientists, and Others) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/newborn-screening-market
Research and data collection play a pivotal role in shaping the newborn screening landscape. Surveys worldwide provide essential insights for researchers and healthcare organizations. Understanding the prevalence of rare diseases is key in making informed decisions regarding newborn screening programs and technology advancements. As a response to this demand, market players are introducing innovative products and surveys to cater to the evolving needs. For instance, in May 2023, Rare Barometer launched a new survey on newborn screening. It is available in 24 different languages and is open to all families affected by a rare disease.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Technology
o By Test Type
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Hill-Rom Holdings, Inc., India Medtronic Pvt. Ltd., Integrated DNA Technologies, LifeCell International Pvt. Ltd., and Masimo Corp., among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Newborn Screening Market Report Segment
By Technology
By Test Type
By End-User
Global Newborn Screening Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/newborn-screening-market